effect of specific cox-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. rofecoxib os...  to determine the efficacy and safety of the  xxxg1884xxx  (cox-2) specific inhibitor, rofecoxib in patients with osteoarthritis (oa) of the knee.